Most stocks have moved in trading today after the Department of Commerce reported a 3% rise in factory orders in February. As of 3:25 p.m. EDT the Dow Jones Industrial Average (DJINDICES: ^DJI ) is up 0.47%, while the S&P 500 (SNPINDEX: ^GSPC ) has gained 0.4%. Interestingly, gains weren't spread evenly among stocks today, and there were some wild moves from some of the largest companies on the market.
UnitedHealth Group (NYSE: UNH ) is up 4.8% today, leading the Dow higher. The Centers for Medicare and Medicaid Services pulled a 180 today, announcing an increase in Medicare Advantage reimbursements of 3.3%. The initial proposal was for a 2.2% cut, which made insurers lobby for higher rates, even threatening to drop coverage. The lobbying worked, and UnitedHealth is one of many medical insurers that have made significantly gains today.
When President Obama was re-elected, shares of UnitedHealth and other health insurers fell immediately. Is Obamacare a death knell for health insurers, or is the market missing out on some of the opportunities the law presents? In this brand-new premium report on UnitedHealth, The Motley Fool takes a long-term view, honing in on prospects for UnitedHealth in a post-Obamacare world. So don't miss out -- simply click here now to claim your copy today.
Home Depot (NYSE: HD ) is second on the Dow, gaining 1.6% so far today. The company sold $2 billion of bonds to help fund a $17 billion share buyback program which the company authorized in February. The bonds due 2023 were sold at just 85 basis points over similar treasuries, which is a great price for a company adding leverage and sending money back to shareholders.
Hewlett-Packard (NYSE: HPQ ) is the big loser on the Dow today, plummeting 5.5%. Goldman Sachs downgraded the company to "sell," citing excessive optimism priced into the stock right now. PC sales slowed rapidly toward the end of 2012, but recent data showing a rise in PC sales has given the market hope for the PC market and driven recent gains at HP. The stock is still a risky bet for investors, and I'd wait to see a solid turnaround in sales and profits before buying in, because even an analyst downgrade can sink the stock in the short term.